Ameritas Investment Partners’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Ameritas Investment Partners’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,558	Closed	-$50K	–	3010
2017 Q3	$50K	Hold	4,558	–	–	﹤0.01%	1899
2017 Q2	$50K	Buy	4,558 +730	+19%	+$7.3K	﹤0.01%	1911
2017 Q1	$38K	Buy	+3,828	New	+$38.2K	﹤0.01%	2028

Ameritas Investment Partners's SCLN Position: Q4 2017 in Review

Ameritas Investment Partners sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 4,558 shares — an estimated $50K sold.

Ameritas Investment Partners first reported a position in SCLN in Q1 2017 and held it in 3 quarters. The position peaked at $50K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Ameritas Investment Partners reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Ameritas Investment Partners sold 4,558 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $50K.
Ameritas Investment Partners first reported a position in Sciclone Pharmaceuticals Inc in Q1 2017 and held it in 3 quarters.
Ameritas Investment Partners's Sciclone Pharmaceuticals Inc position peaked at $50K in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Ameritas Investment Partners's 13F filing for Q4 2017, filed 14 Feb 2018.